Results 161 to 170 of about 21,804,485 (185)
Some of the next articles are maybe not open access.

Positioning of Rifampicin in the Biopharmaceutics Classification System (BCS)

Clinical Research and Regulatory Affairs, 2006
The position of rifampicin with respect to the biopharmaceutics classification system (BCS) was explored on the basis of its aqueous solubility and intestinal permeability. The aqueous solubility was determined between pH 1 and 7 by the conventional shake-flask method.
T.T. Mariappan, Saranjit Singh
openaire   +3 more sources

Impact of the US FDA “Biopharmaceutics Classification System” (BCS) Guidance on Global Drug Development

Molecular Pharmaceutics, 2017
The FDA guidance on application of the biopharmaceutics classification system (BCS) for waiver of in vivo bioequivalence (BE) studies was issued in August 2000. Since then, this guidance has created worldwide interest among biopharmaceutical scientists in regulatory agencies, academia, and industry toward its implementation and further expansion.
Mehul U, Mehta   +14 more
openaire   +4 more sources

Very rapid dissolution is not needed to guarantee bioequivalence for biopharmaceutics classification system (BCS) I drugs

Journal of Pharmaceutical Sciences, 2010
Currently, the EMEA, FDA, and WHO as regulatory authorities accept rapidly dissolving (>85% dissolved in 30 min) biopharmaceutics classification system (BCS) I drug products for biowaiver candidates. In the draft EMEA guideline the requirement has been set tighter, that is, the drug product should be very rapidly dissolving (>85% dissolved in 15 min ...
H, Kortejärvi   +5 more
openaire   +4 more sources

Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

Pharmaceutical Research, 2005
The Biopharmaceutics Classification System (BCS) was developed to allow prediction of in vivo pharmacokinetic performance of drug products from measurements of permeability (determined as the extent of oral absorption) and solubility. Here, we suggest that a modified version of such a classification system may be useful in predicting overall drug ...
Chi-Yuan, Wu, Leslie Z, Benet
openaire   +4 more sources

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms Based on Biopharmaceutics Classification System (BCS) Literature Data: Verapamil Hydrochloride, Propranolol Hydrochloride, and Atenolol

open access: yesJournal of Pharmaceutical Sciences, 2004
Literature data related to the Biopharmaceutics Classification System (BCS) are presented on verapamil hydrochloride, propranolol hydrochloride, and atenolol in the form of BCS-monographs.
Gordon L. Amidon   +2 more
exaly   +2 more sources

Summary Workshop Report: Bioequivalence, Biopharmaceutics Classification System, and Beyond

open access: yesAAPS Journal, 2008
The workshop "Bioequivalence, Biopharmaceutics Classification System, and Beyond" was held May 21-23, 2007 in North Bethesda, MD, USA. This workshop provided an opportunity for pharmaceutical scientists to discuss the FDA guidance on the Biopharmaceutics
James E Polli   +2 more
exaly   +2 more sources

Comparative Bioavailability of Two Formulations of Biopharmaceutical Classification System (BCS) Class IV Drugs: A Case Study of Lopinavir/Ritonavir

Journal of Pharmaceutical Sciences, 2021
Lopinavir/ritonavir (LPV/r-A, Kaletra®), a fixed dose, co-formulated antiviral therapy for the treatment of HIV infection has been used worldwide for over two decades. Both active substances have low solubility in water and low membrane permeability. LPV/r-A tablets contain key excipients critical to ensuring acceptable bioavailability of lopinavir and
Ahmed M, Saeed   +6 more
openaire   +2 more sources

[Biopharmaceuticals classification system(BCS) of nuciferin in Nelumbinis Folium].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2019
Nuciferin is the main active ingredients in Nelumbinis Folium, which was proved to have good hypolipidemic, antioxidative and anti-inflammatory bioactivities. Currently, in vivo pharmacokinetic studies of nuciferin showed different results based on different animal models.
Jun-Rui, Zhao   +2 more
openaire   +1 more source

Possibility of extending biopharmaceutics classification system based biowaiver to BCS class IIa drug

Pakistan Journal of Pharmaceutical Sciences, 2019
Biowaiver studies have been performed to assess the bioequivalence of two drug products. Ibuprofen is a Biopharmaceutics Classification System (BCS) class IIa drug (Low solubility - High permeability) used as analgesic, antipyretic and anti-inflammatory agent.
openaire   +1 more source

Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).

Neuro endocrinology letters, 2010
The Caco-2 cell monolayer model is widely used as a standard screening tool for studying the mechanisms of cellular drug transport. Caffeine was chosen as a model drug and is supposed to be class I of the Biopharmaceutics Classification System (BCS). Our study was conducted 1) to characterize the mechanisms of caffeine transport across the intestinal ...
Libuse, Smetanova   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy